Background: Urinary excretion of D-xylose by suckling rats after ingestion of a mixture of 4-, 3-, and 2-galactosylxyloses reflects lactase activity in vivo. We aimed to select the most convenient of these disaccharides for detecting the changes of the enzyme activity in vivo and to optimize the method. Methods: 4-, 3-, and 2-Galactosylxyloses were synthesized and purified, then orally administered to suckling rats of different ages. D-xylose was measured colorimetrically by the phloroglucinol reaction in urine and plasma. Lactase activity was determined in extracts of small intestine mucosa with lactose, galactosylxyloses, and phlorizin as substrates. Results: D-xylose appeared in the urine in a dosedependent manner after giving any of the 3 galactosylxylose disaccharides. Correlation between D-xylose elimination and intestinal lactase activity was highest with 4-galactosylxylose (r ‫؍‬ 0.97; n ‫؍‬ 24), lower with 2-galactosylxylose (r ‫؍‬ 0.89; n ‫؍‬ 24), and lowest with 3-galactosylxylose (r ‫؍‬ 0.34; n ‫؍‬ 23). The kinetic properties of intestinal lactase accounted for these differences. D-xylose concentration in plasma after administering 4-galactosylxylose also correlated with lactase activity (r ‫؍‬ 0.93; n ‫؍‬ 33).
reliability, because they can be influenced by a number of factors (3, 5, 6, 8 ) , as is well documented for the breath hydrogen test (1, 6, 10, 11, 12, 13 ) ; and (b) the abdominal discomfort produced in intolerant patients by the unphysiologically high doses of lactose [usually 50 (5, 6, 7, 8, 9, 10 ) or 25 g (11, 12 ) ]. In some cases, highly sophisticated equipment is required (10, 11, 12 ) . Therefore, a new method for evaluation is necessary.
We developed a new, noninvasive method based on oral administration of 4-galactosylxylose, a close structural analog of lactose, which is hydrolyzed by intestinal lactase yielding 2 physiologic products, galactose and xylose (14, 15 ) . D-xylose is passively absorbed from the small intestine (16, 17 ) and is accumulated in the urine (14, 15 ) , where it could be measured by a simple colorimetric method (18 ) . To overcome the complexity and inefficiency of the chemical synthesis of 4-galactosylxylose, we carried out an enzymatic synthesis involving only 1 reaction step (19 ) , which produced a final preparation with high yield, but consisting of a mixture of 2-, 3-, and 4-galactosylxyloses ( Fig. 1) , although urinary excretion of D-xylose followed administration of this mixture (19 ) . Distinct kinetic properties of the 3 regioisomers, observed with lamb intestinal lactase in vitro (19 ) , suggested that they could behave differently in vivo.
In view of the potential advantages of this method, we examined the efficiency of each of the 3 galactosylxylose disaccharides in detecting the changes of rat lactase activity in vivo, so that we might select the one most suitable for the noninvasive evaluation of the enzyme.
Materials and Methods chemicals
Phlorizin, phloretin, sugars, and phloroglucinol (1, 3, 5-trihydroxybenzene) were from Sigma. All other chemicals were from commercial sources and were of analytical grade.
synthesis of galactosylxyloses
The synthesis of 4-, 3-, and 2-O-␤-D-galactopyranosyl-Dxylose disaccharides (4-, 3-, and 2-galactosylxylose, respectively) was performed in one reaction step by enzymatic ␤-D-galactosylation of D-xylose, following our previous work on this topic (19, 20, 21 ) . Nevertheless, further modifications were introduced to obtain pure disaccharides in gram scale that might facilitate a simple and inexpensive scaling up of their production (G. Corrales, C. Hermida, J.J. Aragó n, F.J. Cañ ada and A. Fernán-dez-Mayoralas, unpublished manuscript). Purity was above 98% for 4-galactosylxylose and ϳ90% for 3-and 2-galactosylxylose, as assessed by gas chromatography. The structure of lactose is included for comparison.
administration of galactosylxyloses to animals and sample collection
Suckling rats of 12-35 days of age were fasted for 6 h in metabolic cages at 30°C, and received an oral gavage of 0.3 mL of an aqueous solution containing the disaccharides or D-xylose. Urine was collected by intermittent transabdominal bladder pressure before and at the time indicated after administration of the compound. Blood samples of ϳ0.4 mL were obtained via cardiac puncture, and plasma was immediately separated by centrifugation at 1000g for 5 min. Urine and plasma samples were stored at Ϫ20°C until analyzed.
measurement of D-xylose
Unless otherwise indicated, D-xylose was determined colorimetrically with phloroglucinol (18 ) , except that the final reaction volume was 1 mL. Absorbance at 554 nm was measured in a Perkin-Elmer Lambda 5 spectrophotometer. In some experiments, a micromethod was also employed for D-xylose determination, using nonsterile, 96-well plates resistant to acid and heat (polypropylene plates, Costar). Each well contained 190 L of the color reagent (0.5 g of phloroglucinol, 100 mL of glacial acetic acid, and 10 mL of concentrated hydrochloric acid) and up to 10 L of the sample in a final volume of 200 L. The plate was sealed with Thermowell TM (Costar), the reaction was led to proceed for 20 min at 100°C in an oven (Heraeus model T5042E) and then stopped by a 10-min incubation at 4°C. Absorbance at 554 nm was read in a microtiter plate reader (Molecular Devices, model EL340). D-xylose determination could be carried out with confidence within a linear interval of 0.25 to 20.0 g of this compound (r ϭ 0.99). In some experiments, D-xylose was also determined by gas chromatography as described below.
assay of intestinal lactase activity
To measure rat intestinal lactase, the mucosa from the medium region of the small intestine was obtained as described (14 ) and homogenized with 10 volumes of 100 mmol/L sodium maleate buffer, pH 6.0. Lactase activity was determined in the homogenate, designated the extract, as described (14 ) by measuring the released galactose with galactose dehydrogenase (22 ) . One unit of enzyme activity is defined as the amount of enzyme catalyzing the conversion of 1 mol of substrate/min at 25°C.
To study the kinetic properties of rat intestinal lactase with 4-, 3-, and 2-galactosylxylose and lactose, substrate hydrolysis was evaluated as the xylose (from galactosylxyloses) or galactose (from lactose) released was measured by gas chromatography as follows. Samples of 50 L of the assay mixture were removed at 0, 10, and 20 min, then boiled for 2 min, frozen, and lyophilized. The dry residue was dissolved in pyridine (20 L) containing 1 mmol/L benzyl ␤-xyloside as internal calibration, and 20 L of the derivatizing agent trymethylsilylimidazol were added. After sonication for 60 s and incubation for 30 min at 60°C, 1-2 L of sample were injected onto a glass capillary column ultra-2 (12 m) with 0.2-mm internal diameter, equipped with a flame ionization detector (Hewlett-Packard model 5890).
Phlorizin hydrolase activity of intestinal lactase was measured in a reaction mixture containing 50 mmol/L sodium phosphate, pH 6.0, 10 mol/L phlorizin, and 10 L of extract in a final volume of 200 L. The phloretin released was determined as described (23 ) . Protein concentration was determined as described (24 ) .
statistics
Results are presented as the mean (SE). Correlations were determined by linear regression analysis (least-squares method). Statistical significance was set at P Ͻ0.05.
Results time course and dose dependence of the urinary elimination of D-xylose derived from 4-galactosylxylose As shown in Fig. 2 , oral administration of 16 mg of 4-galactosylxylose to suckling rats led to a progressive elimination of D-xylose in the urine, which reached a peak 3 h after ingesting the disaccharide and was completed after 7 h, so that 98% of the pentose accumulated in the urine after 6 h. The latter time was selected as the optimal period for urine collection.
Elimination of urinary D-xylose increased linearly with increasing doses (from 2 to 32 mg) of the disaccharide (see Table 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem/ content/vol52/issue2). However, the percentage of D- xylose eliminated was similar for all doses, averaging 22.8 (0.4)% of the administered amount of 4-galactosylxylose. Similar results were obtained with 3-and 2-galactosylxylose (data not shown), evidencing that they are also substrates of intestinal lactase in vivo. Therefore, the disaccharide dose could be reduced to at least 4 mg for highly confident measurements of urinary D-xylose.
When 1, 2, 4, 8, and 16 mg of D-xylose were given to suckling rats of 15, 18, and 30 days of age (4 animals for each dose and age), the proportion of the pentose recovered in the urine averaged 52.1 (0.1)% of the amount given, being independent of dose and age. This percentage was above that of the urinary D-xylose resulting from 4-galactosylxylose ]22.8 (0.4)%[, indicating that D-xylose uptake was not saturated under the conditions of Table 1 found in the online Data Supplement. Endogenous metabolization may account for most of the remainder 48% of administered D-xylose. In humans, D-threitol is the main end product of D-xylose catabolism (25 ) , but the exact metabolic pathway is unknown in mammals.
correlation between urinary elimination of d-xylose derived from 4-, 3-, and 2-galactosylxylose and lactase activity Fig. 3 shows how D-xylose elimination in 6-h urine after administration of 4 mg of each galactosylxylose to suckling rats, correlates with the physiologic decrease of lactase activity measured directly in intestinal mucosa extracts along animal growth. As seen in Fig. 3A , D-xylose elimination reached a maximum of ϳ22% at the 15th day with either disaccharide, followed by a gradual decrease, which was strongly different with the 3 compounds. The pattern of 4-galactosylxylose reflected the normal decrease of lactase activity in the postweaning period, whereas the decrease of D-xylose elimination was lower than the enzyme decrease with 2-galactosylxylose, and much lower with 3-galactosylxylose, so that the urinary pentose excretion at day 35 diminished by 65.6 (2.1)% and 42.2 (1.8)%, respectively, compared with the values at day 15. In contrast, 4-galactosylxylose elicited a decrease of 93.1 (0.3)% during the same period, which practically coincided with that of lactase activity (93.7 (0.5)%. Therefore, correlation between D-xylose elimination and lactase activity was the highest with 4-galactosylxylose, lower with 2-galactosylxylose, and very low with 3-galactosylxylose (Fig. 3B ).
kinetic characteristics of rat intestinal lactase with galactosylxylose disaccharides
The different behavior of the 3 galactosylxyloses in vivo suggested that intestinal lactase hydrolyzed them with distinct catalytic efficiency. This was tested by determining the kinetic parameters of the enzyme for these substrates and for lactose. As demonstrated in Table 1 , rat lactase exhibited the highest affinity for 3-galactosylxylose (K m 8.5 mmol/L) and the lowest for 4-galactosylxylose (K m 58.8 mmol/L), which also yielded the lowest V max value (11% of that with lactose). Thus, the V max /K m ratio indicated a much lower specificity of the enzyme for 4-galactosylxylose (3.5% for lactose) than for 3-galactosylxylose, which gave a ratio (187%) even higher than lactose. Kinetic properties with 2-galactosylxylose were somewhere in between those found with the 2 other regioisomers.
The marked differences observed in the kinetic behavior of 4-and 3-galactosylxylose led us to analyze the Fig. 3 . Elimination of D-xylose in the urine of suckling rats after oral administration of 4-galactosylxylose (4GX), 3-galactosylxylose (3GX), and 2-galactosylxylose (2GX), and intestinal lactase activity as a function of age.
(A), A distinct group of suckling rats from 2 different litters and of the same age (12 days) was used for each disaccharide. These groups were composed of 24 animals each for 4GX and 2GX, and of 23 animals for 3GX. Rats were orally administered 4 mg of the corresponding disaccharide. D-xylose derived from either 4GX (•), 3GX (OE). or 2GX (f) and was eliminated in the first 6-h urine collected after disaccharide administration was determined. The intestinal lactase activity (⅜) was determined postmortem in 4 rats from each group of animals, except for the group that received 3GX, in which 3 animals were killed on the day 12. The remaining animals were returned to maternal nursing, and the experiment was repeated at the indicated age until all the rats were killed. Urinary D-xylose in each group of animals was determined using 20, 20, 16, 12, 8, contribution of the 2 catalytic activities of the enzyme, lactase and phlorizin hydrolase, to the hydrolysis of both substrates in vivo. This was investigated by determining urinary D-xylose in suckling rats after giving them increasing concentrations of glucal, a competitive inhibitor of the enzyme at the lactose site (23 ), mixed with either 4 mg of 4-galactosylxylose or 1 mg of 3-galactosylxylose. Fig. 4A shows that D-xylose elimination was inhibited maximally above 50 -100 mmol/L glucal, decreasing no more than 40% from 4-galactosylxylose, and 75% from 3-galactosylxylose. This suggested that a major proportion of 4-galactosylxylose is split at the phlorizin hydrolase site, whereas most of 3-galactosylxylose is split at the lactose site. Accordingly, in vitro studies with rat intestinal lactase (Fig. 4B ) revealed that inhibition of 4-galactosylxylose hydrolysis was not higher than 35%, with a minimal effect on phlorizin hydrolysis, whereas inhibition of 3-galactosylxylose hydrolysis reached 74%, close to the 84% decrease of lactose hydrolysis. Because the lactose site splits glycosides with hydrophilic aglycons, whereas the phlorizin site preferentially splits glycosides with hydrophobic aglycons (1 ), these findings suggest that the lack of the HO-6 group in 4-galactosylxylose provides a more hydrophobic environment for enzyme binding, thereby restraining its interaction with the lactose site.
noninvasive evaluation of intestinal lactase activity with 4-galactosylxylose by measuring D-xylose in plasma
As seen in Fig. 5A , D-xylose markedly accumulated in plasma after administration of 16 mg of 4-galactosylxylose to suckling rats, reaching a maximum ϳ3 h after the oral gavage and gradually diminishing to values close to the initial concentrations after 6 h. When 4, 8, and 16 mg of 4-galactosylxylose were given to suckling rats (15 days of age pertaining to the same litter and using 4 animals for each dose), the concentration of D-xylose in 3-h plasma increased linearly and corresponded to 3.6 (0.5), 11.7 (0.6), and 22.0 (1.1) g/100 L, respectively. Fig. 5B shows that, as observed with the urinary pentose, the concentrations of D-xylose determined in plasma 3 h after administering 8 mg of 4-galactosylxylose to suckling rats, correlated strongly with lactase activity determined directly in intestinal mucosa samples obtained postmortem along animal growth.
determination of D-xylose by other methods
The concentrations of D-xylose in both 3-h plasma and 6-h urine from suckling rats of 15 and 30 days old, which received 4-galactosylxylose under conditions similar to those shown in Figs. 3 and 5B, were also determined by gas chromatography and by a micromethod developed to measure the phloroglucinol reaction with a microtiter plate reader using 96-well plates, as described in Material and Methods. Both procedures gave results similar to those Kinetic parameters were determined as described in Materials and Methods. Lactase activity was assayed in intestinal mucosa extracts of suckling rats without further purification to approach physiological conditions. a V max /K m ratios for galactosylxyloses are indicated relative to the value obtained for lactose. Clinical Chemistry 52, No. 2, 2006 described above (data not shown). The phloroglucinol microassay not only facilitated the simultaneous performance of a great number of measurements, but also allowed us to use a considerably smaller volume of sample (10 L).
Discussion
In this study, we have optimized a new method in experimental animals based in the measurement of Dxylose in either urine or blood after ingestion of the synthetic lactose analog 4-galactosylxylose. This compound was obtained with high purity after enzymatic synthesis and was compared with the regioisomers 3-and 2-galactosylxylose, which are also produced by this procedure. The 3 disaccharides behaved as substrates of intestinal lactase in vivo and yielded the same percentage of urinary D-xylose, ϳ22%, when administered at doses ranging 2-32 mg to 15 days old suckling rats that contained the highest concentrations of enzyme activity (Fig. 3) . This value indicated that the entire oral dose of galactosylxylose was hydrolyzed by the intestinal enzyme, because it practically coincided with the percentage of D-xylose (23%) expected from 100% hydrolysis.
The urinary recovery of D-xylose was 52% of the pentose given, and the D-xylose moiety accounts for 45% of the disaccharide molecular weight. However, 4-galactosylxylose was the most effective compound to evaluate lactase activity in vivo, as it elicited the highest correlation (r ϭ 0.97) between urinary elimination of D-xylose and the physiologic decrease of the enzyme activity. The kinetic behavior of rat intestinal lactase with the 3 regioisomers accounted for their different behavior in vivo. Inasmuch as the highest specificity constant (taken as the V max /K m ratio) was obtained with 3-galactosylxylose (Table 1) , the catalytic efficiency in vivo was high enough to hydrolyze a relatively high proportion of this disaccharide even when the enzyme activity was at its lowest concentrations (day 35). Consequently, D-xylose excretion decreased after weaning to a degree lower than that of enzyme activity. The opposite was the case of 4-galactosylxylose, in which low specificity constant allowed the change of both measurements to a similar extent. Paradoxically, it is the worst substrate that turned out to be most suitable to detect the changes in lactase activity in vivo with high reliability. These results agree with previous reports on the role of each hydroxyl group of the lactose molecule in its interaction with intestinal lactase isolated from lamb (26, 27 ) . We obtained evidence that the rate-limiting step in the overall absorption of D-xylose from 4-galactosylxylose is not its transport but the hydrolysis of the disaccharide by lactase, and that this compound does not permeate the intestinal mucosa, as reported for lactose (1, 28 ) . This was shown by the strong correlation between D-xylose from 4-galactosylxylose and intestinal lactase activity, and also by the fact that 100% of the disaccharide was hydrolyzed in vivo when administered at the age of maximal lactase content (day 15).
We found that evaluation of lactase activity in vivo with 4-galactosylxylose can also be carried out by measuring D-xylose in plasma, as indicated by the high correlation between the plasma concentrations of the pentose and enzyme activity (r ϭ 0.93; Fig. 5B ). This provides an alternative to urine D-xylose measurement, especially in young children and infants, where collection of urine can be troublesome. Additionally, determination of blood D-xylose in combination with its urinary content has been shown to improve the accuracy of the D-xylose testing of intestinal absorption (17, 29 ) , as other factors like renal dysfunction, delayed gastric emptying, or portal hypertension can give false low concentrations of urinary D-xylose. The present method is a simple, low-cost, rapid colorimetric test requiring only routinely available equipment. Additionally, D-xylose determination by the phloroglucinol reaction (18 ) is highly sensitive, so that 0.25 g of the pentose can be confidently detected. Consequently, reliable measurements could be made even in a decrease of over 90% lactase, such as that observed in 35-days old rats, by either urine or plasma determinations. This suggests that the dose of disaccharide administered to humans could be lower in comparison with other noninvasive tests and, therefore, with a possible reduction of abdominal discomfort in hypolactasia patients. Although gastrointestinal symptoms after lactose loading can be of help for further treatment, they are unreliable as a diagnostic test (2, 3, 6, 8, 9 ) and provide no information on the ability of the intestine to digest smaller, more physiologic quantities of lactose. In contrast, measurement of D-xylose in the urine or plasma reflects, the overall lactase activity in vivo, indicating the total lactose digestive capacity of the small intestine. This can be an interesting advantage over enzyme activity data obtained from biopsy specimens, usually taken from the proximal small intestine, where lactase is low (30, 31 ) , in addition to the possible patchy expression of the enzyme (1, 32 ) .
Single nucleotide polymorphisms upstream from the lactase gene have been associated with adult-type hypolactasia (33, 34 ) and tested to identify individuals with genetic disposition for this disorder (35, 36 ) . A functional test of lactase activity is essential, however, for proper assessment of the patient situation, because both residual enzyme activity and clinical symptoms can vary within an ample range, and low lactase activity can have other causes.
The simplicity of the synthesis of 4-galactosylxylose, requiring neither toxic nor expensive chemicals (19, 20, 21 ) , is another innovative aspect of this methodology. In fact, toxicology studies have revealed that the synthetic disaccharide is devoid of apparent side effects in animals (data not shown). The method optimized in this work is, therefore, ready for clinical trials, so that it might be applied within the primary healthcare system as a convenient, noninvasive new test for diagnosis of hypolactasia.
